Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential†of Japan’s healthcare industry.
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential†of Japan’s healthcare industry.
View original source →
Pharmaceutical Technology
Tomasz Tunguz
Forbes Business Blog
Capital Numbers
The Next Web
Boing Boing » Politics
Healthcare Informatics Magazine